Clinical Trial Update: A Phase II Study Evaluating the Role of Androgen Receptors as Targets for Therapy of Pre-treated Post-menopausal Patients With ER/PgR-negative/AR-positive or ER and/or PgRpositive/ AR-positive Metastatic Breast Cancer (ARTT) [Phase 2]

View source ↗

Summary

Phase II study evaluating androgen receptor–targeted therapy in pre-treated postmenopausal patients with ER/PR status and AR positivity in metastatic breast can…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Androgen Receptor-positive Breast Cancer
• Breast Cancer
• Estrogen Receptor Negative Breast Cancer
• Estrogen Receptor-positive Breast Cancer
• Progesterone Receptor-negative Breast Cancer
• Progesterone Receptor-positive Breast Cancer

Snippet

Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS | Conditions: Metastatic Breastcancer, Estrogen Receptor Positive Breast Cancer | Phase 2 | Status: TERMINATED